Cargando…

Nanoparticle delivery systems for substance use disorder

Innovative breakthroughs in nanotechnology are having a substantial impact in healthcare, especially for brain diseases where effective therapeutic delivery systems are desperately needed. Nanoparticle delivery systems offer an unmatched ability of not only conveying a diverse array of diagnostic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasina, Vishal, Mownn, Robert J., Bahal, Raman, Sartor, Gregory C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960682/ https://www.ncbi.nlm.nih.gov/pubmed/35351961 http://dx.doi.org/10.1038/s41386-022-01311-7

Ejemplares similares

Next-generation poly-L-histidine formulations for miRNA mimic delivery
por: Kasina, Vishal, et al.
Publicado: (2023)

Noncoding RNA therapeutics for substance use disorder
por: Seyednejad, Seyed Afshin, et al.
Publicado: (2022)

Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro
por: Malik, Shipra, et al.
Publicado: (2019)

Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids
por: Malik, Shipra, et al.
Publicado: (2020)

Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy
por: Wahane, Aniket, et al.
Publicado: (2020)

Biomarkers of the Endocannabinoid System in Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2022)

Telemedicine Mediated Service Delivery for Substance Use Disorders
por: Basu, D
Publicado: (2022)

Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy
por: Dhuri, Karishma, et al.
Publicado: (2021)

In utero nanoparticle delivery for site-specific genome editing
por: Ricciardi, Adele S., et al.
Publicado: (2018)

Borderline personality disorder and substance use disorders: an updated review
por: Trull, Timothy J., et al.
Publicado: (2018)

A review of gambling disorder and substance use disorders
por: Rash, Carla J, et al.
Publicado: (2016)

Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy
por: Amato, Rosario, et al.
Publicado: (2018)

Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders
por: Buchke, Sakshi, et al.
Publicado: (2022)

Substance use and substance use disorders in Africa: An epidemiological approach to the review of existing literature
por: Onaolapo, Olakunle James, et al.
Publicado: (2022)

Brief intervention in substance use disorders
por: Mattoo, Surendra Kumar, et al.
Publicado: (2018)

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
por: Semple, Sean C., et al.
Publicado: (2022)

Genetics of substance use disorders: a review
por: Deak, Joseph D., et al.
Publicado: (2021)

New Technologies Bloom Together for Bettering Cancer Drug Conjugates
por: Jin, Yiming, et al.
Publicado: (2022)

Mood Disorders and Substance Use Disorder: A Complex Comorbidity
por: Quello, Susan B., et al.
Publicado: (2005)

Nanoparticle-Based Delivery Systems for Vaccines
por: Bezbaruah, Rajashri, et al.
Publicado: (2022)

The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis
por: Devoe, Daniel J., et al.
Publicado: (2021)

Use of array CGH for molecular characterization of genetic disorders
por: Bahal, Ashish, et al.
Publicado: (2014)

Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders
por: Andersen, Allan M., et al.
Publicado: (2015)

Biomarkers and neuromodulation techniques in substance use disorders
por: Habelt, Bettina, et al.
Publicado: (2020)

Bipolar Disorder and Comorbid Use of Illicit Substances
por: Preuss, Ulrich W., et al.
Publicado: (2021)

The role of enkephalinergic systems in substance use disorders
por: Rysztak, Lauren G., et al.
Publicado: (2022)

Innovative Delivery and Release Systems for Antioxidants and Other Active Substances in the Treatment of Cancer
por: Sezgin-Bayindir, Zerrin, et al.
Publicado: (2023)

Prevention of substance use disorders in the community and workplace
por: Malick, Reshma
Publicado: (2018)

Substance use disorders: diagnosis and management for hospitalists
por: Pasha, Ahmed K., et al.
Publicado: (2020)

Delivery and payment reform in Massachusetts: substance use disorder treatment organizations’ perspectives
por: Quinn, Amity E, et al.
Publicado: (2015)

Telemedicine-assisted stepwise approach of service delivery for substance use disorders in India
por: Ghosh, Abhishek, et al.
Publicado: (2021)

A review of the public sector substance use disorder treatment and prevention systems in Kenya
por: Jaguga, Florence, et al.
Publicado: (2020)

Male Adolescent Substance Use Disorder and Attention-Deficit Hyperactivity Disorder: A Review of the Literature
por: Eme, Robert
Publicado: (2012)

Addressing substance abuse and violence in substance use disorder treatment and batterer intervention programs
por: Timko, Christine, et al.
Publicado: (2012)

Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy
por: Cho, Kyeong Jin, et al.
Publicado: (2022)

Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System
por: Muluh, Tobias Achu, et al.
Publicado: (2021)

Vaccine delivery using nanoparticles
por: Gregory, Anthony E., et al.
Publicado: (2013)

Zein Microparticles and Nanoparticles as Drug Delivery Systems
por: De Marco, Iolanda
Publicado: (2022)

Magnetic nanoparticles as targeted delivery systems in oncology
por: Prijic, Sara, et al.
Publicado: (2011)

Protein-Based Nanoparticles as Drug Delivery Systems
por: Hong, Seyoung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vk2pktt8cnuf97d9elcqkd6vsh